James Rand's most recent trade in Tonix Pharmaceuticals Holding Corp was a trade of 7,740 Stock Option done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Hold... | James Randolph Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 7,740 | 7,740 | - | - | Stock Option | |
| ProFrac Holding Corp - Ord... | James C. Randle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,916 | 662,647 | - | 0 | Class A Common Stock, par value $0.01 | |
| ProFrac Holding Corp - Ord... | James C. Randle | Director | Sale or transfer of securities back to the company at price $ 22.08 per share. | 25 Apr 2024 | 660,000 | 627,602 | - | 22.1 | 14,572,800 | Class A Common Stock, par value $0.01 |
| ProFrac Holding Corp - Ord... | James C. Randle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 16,129 | 643,731 | - | 0 | Class A Common Stock, par value $0.01 |